Skip to main content

Table 2 Main features of reported cases of Helcococcus kunzii infections

From: Infectious endocarditis caused by Helcococcus kunzii in a vascular patient: a case report and literature review

Sex/age of patient (years) Underlying condition(s) Type of infection Treatment Outcome Other bacteria Methods of identification Author
M/41 IV-drugs user Bacteraemia 3 weeks of penicillin G and cloxacillin IV Recovery None -API 20 Strep system, (bioMérieux, Marcy l’Etoile, France), (code 4100413)-16S rDNA gene sequencing Woo et al. 2005 [5]
M/83 Hypertension, diabetes, prostate cancer Brain abscess 2 weeks of ceftriaxone and metronidazole IV, then oral amoxicillin-clavulanic acid and then ceftriaxone and metronidazole and vancomycin IV. Total duration of antimicrobial therapy 12 weeks. Recovery None -Vitek2 system, (bioMérieux, Marcy l’Etoile, France) -Matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF MS; Vitek MS bioMérieux) -16S rDNA gene sequencing Sridhar et al. 2014 [19]
M/55 Smoker, alcoholic and IV-drugs user Empyema thoracic 8 weeks of amoxicillin-clavulanic acid Recovery None -API 20 Strep system, (code 4100413)  -16S rDNA gene sequencing Woo et al.2005 [5]
M/39 Osteochondritis Prosthetic joint chronic infection Clindamycin and gentamicin Recovery None -API 20 Strep system,(code 4100413)   -16S rDNA gene sequencing Perez-Jorge et al. 2011 [4]
M/75 NA Infection of implantable cardiac device Association of flucloxacilline (2 g × 4/day) and benzylpenicllin (2.4 × 4/day) IV then association of vancomycin and clindamycin (14 days) IV and then association of oral amoxicillin and rifampicin for four weeks Recovery None -BBL CrystalTM System (Baltimore, MD, USA)-BD Phoenix TM Automated Microbiology System (Baltimore, MD, USA) -16S rDNA gene sequencing Mc Nicholas et al. 2011 [6]
W/57 None Breast abscess Oral cephalexin (0.5 g/day) for 5 days Recovery None -API 20S Strep system, (code 4100413),-16S rDNA gene sequencing Chagla et al. 1998 [13]
W/36 None Post chirurgical foot abscess Pristinamycine and rifampicin Recovery None -Rapid ID 32 Strep system (bioMérieux, Marcy l’Etoile, France), (Aerococcus viridans) -16S rDNA gene sequencing Riegel et al. 2003 [18]
M/36 High blood pressure, obesity and hypercholesterolemia Sebaceous cyst infection associated with cellulitis Flucloxacillin (1 g × 4/day) IV and then oral flucloxacillin (0.5 g × 4/day) for 5 days Recovery None -API 20 Strep system, (code 4100413) Peel et al. 1997 [12]
M/86 Malignant melanoma and congenital thrombocytopenia Osteomyelitis Cefuroxime (3 × 1.5 g/day) and metronidazole (2 × 500 mg/day) and then amoxicillin-clavulanic acid (2 × 1 g/day) for 6 weeks PO Recovery Anaerobic bacteria and germs of normal skin flora Not available Stanger et al. 2013 [17]
M/68 Coronary artery disease and colonic polyps Inner thigh wound from trauma Vancomycin and piperacillin-tazobactam inpatient and cephalexin outpatient NA Staphylococcus aureus -API 20 Strep system and VITEK 2 (bioMérieux, Marcy l’Etoile, France), Chow et al. 2014 [11]
-16S rDNA gene sequencing
M/25 Post-traumatic stress disorder Toe abscess Sulfamethoxazole, cephalexin NA Staphylococcus aureus -API 20 Strep system and VITEK 2, Chow et al. 2014 [11]
-16S rDNA gene sequencing
M/79 Hypertension and severe intermittent claudication of both legs Plantar phlegmon Amoxicillin-clavulanic acid (3 weeks), surgical debridement and incision and drainage of the phlegmon NA Klebsiella oxytoca, Bacteroides fragilis -VITEK 2 GP card identification system (bioMérieux, Marcy l’Etoile, France) -16S rDNA gene sequencing Lemaître et al. 2008[16]
M/58 Diabetes and end-stage renal disease Ulcerative lesion of foot 3 weeks of piperacillin/tazobactam IV Recovery Proteus mirabilis -Matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF MS; Bruker GmbH, Bremen, Germany) Park et al. 2014 [15]
-Vitek2 GP system (bio-Mérieux, Marcy l’Etoile, France)
-16S rDNA gene sequencing